Evidence map›Paper›PMID 32077397›Full record

ArticleThe British journal of nutrition2020

Yogurt consumption and colorectal polyps.

Samara B Rifkin, Francis M Giardiello, Xiangzhu Zhu, Linda M Hylind, Reid M Ness, Julia L Drewes, Harvey J Murff, Emma H Spence, Walter E Smalley, Joell J Gills and 7 more

Open access · greenAbstract read
In one paragraph

Article in The British journal of nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Adult-Attained Height and Colorectal Cancer Risk: A Cohort Study, Systematic Review, and Meta-Analysis.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Pooled it
  3. Article
  4. Article
  5. Observational
  6. Review
  7. Article
  8. Review
  9. De- "bug"-ing the microbiome in lung cancer.Cancer metastasis reviews · 2022
    Review
  10. Observational
  11. Postbiotics, Metabolic Signaling, and Cancer.Molecules (Basel, Switzerland) · 2021
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 1 country.

Samara B RifkinDepartment of Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.
Francis M GiardielloDepartment of Medicine, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Xiangzhu ZhuDepartment of Medicine, Division of Epidemiology, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Linda M HylindDepartment of Medicine, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Reid M NessVanderbilt Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Center, Nashville, TN, USA.
Julia L DrewesBloomberg-Kimmel Institute for Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Harvey J MurffDepartment of Medicine, Division of General Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
Emma H SpenceBloomberg-Kimmel Institute for Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Walter E SmalleyGastroenterology Section or Geriatric Research, Department of Veterans Affairs, Education and Clinical Center (GRECC), Tennessee Valley Healthcare System, Nashville, TN, USA.
Joell J GillsBloomberg-Kimmel Institute for Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Gerard E MullinDepartment of Medicine, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
David KafonekDepartment of Medicine, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Louis La LunaDigestive Disease Associates, Wyomissing, PA, USA.
Wei ZhengDepartment of Medicine, Division of Epidemiology, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Cynthia L SearsDepartment of Medicine, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Martha J ShrubsoleDepartment of Medicine, Division of Epidemiology, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Biofilm Study Consortium
Johns Hopkins University · USJohns Hopkins Medicine · USVanderbilt University · USVanderbilt University Medical Center · USBloomberg (United States) · USDigestive Care (United States) · USGeriatric Research Education and Clinical Center · USUniversity of Michigan–Ann Arbor · USVA Tennessee Valley Healthcare System · US

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI WILLIAM George NELSON · 1985 to 2026
$208.6M
Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STACIE B DUSETZINA · 1995 to 2026
$172.8M
Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
Tumor Antigens for Individual Signatures and TherapyP50CA062924 · NCI · JOHNS HOPKINS UNIVERSITY · PI JAFFEE, ELIZABETH M. · 1993 to 2022
$54.6M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Molecular, Cellular and Tissue Characterization UnitU2CCA233291 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COFFEY, ROBERT J., SHRUBSOLE, MARTHA J. · 2018 to 2023
$12.2M
Biofilm Epidemiology and Mechanisms in Colon CancerR01CA196845 · NCI · JOHNS HOPKINS UNIVERSITY · PI GIARDIELLO, FRANCIS M, SEARS, CYNTHIA · 2016 to 2020
$4.3M
Tumor Markers and Recurrent Adenomas: A Follow-up StudyR01CA097386 · NCI · VANDERBILT UNIVERSITY · PI ZHENG, WEI · 2002 to 2006
$3.6M
Diet, Genetics, Epigenetics and Colorectal Adenoma Risk.K07CA122451 · NCI · VANDERBILT UNIVERSITY · PI SHRUBSOLE, MARTHA J. · 2007 to 2011
$655k
NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1 TR001079NCI NIH HHS K07 CA122451NCI NIH HHS P30 CA006973NCI NIH HHS P30 CA068485NCI NIH HHS P50 CA062924NCI NIH HHS R01 CA097386NCI NIH HHS R01 CA196845NCI NIH HHS U2C CA233291NIDDK NIH HHS P30 DK058404
6 · The paper itself

Abstract

Diet modifies the risk of colorectal cancer (CRC), and inconclusive evidence suggests that yogurt may protect against CRC. We analysed the data collected from two separate colonoscopy-based case-control studies. The Tennessee Colorectal Polyp Study (TCPS) and Johns Hopkins Biofilm Study included 5446 and 1061 participants, respectively, diagnosed with hyperplastic polyp (HP), sessile serrated polyp, adenomatous polyp (AP) or without any polyps. Multinomial logistic regression models were used to derive OR and 95 % CI to evaluate comparisons between cases and polyp-free controls and case-case comparisons between different polyp types. We evaluated the association between frequency of yogurt intake and probiotic use with the diagnosis of colorectal polyps. In the TCPS, daily yogurt intake v. no/rare intake was associated with decreased odds of HP (OR 0·54; 95 % CI 0·31, 0·95) and weekly yogurt intake was associated with decreased odds of AP among women (OR 0·73; 95 % CI 0·55, 0·98). In the Biofilm Study, both weekly yogurt intake and probiotic use were associated with a non-significant reduction in odds of overall AP (OR 0·75; 95 % CI 0·54, 1·04) and (OR 0·72; 95 % CI 0·49, 1·06) in comparison with no use, respectively. In summary, yogurt intake may be associated with decreased odds of HP and AP and probiotic use may be associated with decreased odds of AP. Further prospective studies are needed to verify these associations.

Indexed as

DietYogurtAdenomatous PolypsAdultAgedCase-Control StudiesColonic PolypsColonoscopyColorectal NeoplasmsFemaleHumansMaleMiddle AgedOdds RatioProbioticsRisk FactorsAdenomatous polypsColorectal polypsHyperplastic polypsProbioticsSerrated polypsSessile serrated polypsYogurt

Identifiers

PMID32077397
PMCPMC7438237
OpenAlexW3008191755

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.